Starch Processing & Sweetener Patents: Top Companies, Trends 2026
- Filings peaked in 2021 at 6 records and have since gone flat, with 2022 at zero — a signal that claim activity in this dataset has cooled rather than accelerated.
- The top 5 assignees hold 61.2% of all 49 records in scope, and the top 10 hold 79.6% — a field concentrated at the top with a thin tail below it.
- C12P fermentation and enzymatic synthesis covers 75.5% of records, far ahead of C13K saccharide-extraction claims at 30.6%, showing where the claim density actually sits.
What this landscape covers
This review covers 49 published records filed between 2015 and 2026 that combine starch processing and sweetener-production search terms with IPC classes C13K, C12P and A23L — the classes covering saccharides from natural sources, fermentation-based synthesis, and food and beverage formulation. The scope centres on the technical steps that turn starch into glucose or high-fructose syrup: enzymatic liquefaction and saccharification, isomerization, ion exchange refining, DE value control, and the handling of co-products like gluten and fiber.
Publication lags filing by roughly 18 months, so the most recent year in the trend chart understates real filing activity. Family-level counting is used throughout so that repeat filings from the same invention in multiple jurisdictions do not inflate any single assignee's position.
Filing trends and technology composition
Two views of the same 49 records: how filing activity moved year over year, and how those records distribute across IPC subclasses.
Filing trend, 2017-2026
Activity rose gradually from 2017, reached a peak of 6 records in 2021, then dropped to zero at the 2022 midpoint — a pattern consistent with a technology area that saw a short filing push rather than sustained growth. Because publication lags filing by about 18 months, the final one or two years on the chart will fill in further as more records publish.
IPC subclass composition
C12P (fermentation and enzymatic synthesis) appears on 75.5% of the 49 records, with C12N (microorganisms and genetic engineering) on 42.9% and C13K (saccharides from natural sources) on 30.6%. Because a single record can carry multiple IPC classes, these shares sum to well over 100% — they show where claim attention concentrates, not a partition of the field. Smaller classes like A21D (baking and doughs) at 6.1% and A23K (animal feed) at 10.2% mark peripheral application areas rather than core process claims.
Shares are the percentage of the 49 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Starch Processing and Sweetener Production with Eureka
This page is one run against one query. Ask Eureka your own question about starch processing and sweetener production and every answer comes back with the patent numbers behind it.
Try EurekaMost-cited records in this dataset
System and method for reducing 5-hydroxymethylfurfural content in high fructose corn syrup
The filing describes a purification train for high-fructose syrup that sequences ion exchange (cation then anion removal), heat exchange, chromatographic separation, blending and decolorization to bring an F42 stream up to F55 while controlling 5-hydroxymethylfurfural formation — a byproduct that forms during isomerization and affects both syrup colour and shelf stability.Filed by Zhejiang Huakang Pharmaceutical, published 2022-12-08.

| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | WO1998022613A1 | Use of carbohydrate-binding domain in starch processing | 47 |
| 2 | US4421852A | Production of high fructose syrup from inulin involving ultrafiltration | 47 |
| 3 | CN101979643A | 一种大米果葡糖浆的制备工艺 | 21 |
| 4 | US8507244B2 | Variants of <i>bacillus </i>sp. TS-23 alpha-amylase with altered properties | 14 |
| 5 | CN102242168A | 用大米生产含量为55%果葡糖浆的工艺 | 14 |
| 6 | US4395292A | High fructose syrup and process for making same | 13 |
| 7 | CN104745563A | 葡萄糖异构酶、基因、突变体、工程菌及应用 | 11 |
| 8 | JP1992500756A | Heat, acid and/or alkali bacterial mutant α – amylase has high stability | 9 |
| 9 | CN106566824A | 一种葡萄糖异构酶、基因、载体、工程菌及其应用 | 8 |
| 10 | CN111100892A | 一种果葡糖浆生产工艺 | 7 |
Citation counts inside a searched corpus favour older filings that have had more time to accumulate citations — read them as a measure of influence on later filings, not as an indicator of current commercial relevance.
Patent titles are shown in the language they were filed in, not translated, so that each record stays verifiable against the original filing — a translated title will not match in Eureka or in any national register. Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the data means for R&D and IP strategy
Three patterns stand out once filing volume, IPC composition and citation weight are read together.
Filing sits with a small group of repeat filers
The leader alone accounts for 13 records, and the top 5 combined hold 61.2% of the 49 records in scope. That leaves a long tail: most of the 30 ranked assignees appear with only one or two filings each, which points to a field where a handful of players set the claim boundaries and everyone else files defensively or opportunistically around them.
Enzymatic and fermentation routes dominate claim language
Three in four records touch C12P fermentation and enzymatic synthesis claims, well ahead of C13K saccharide-extraction claims at 30.6%. Enzyme variant and process-condition claims are where the density is; anyone drafting around liquefaction or saccharification steps should expect to find prior art here first.
No leading assignee shows recent-year filing activity
Every one of the six assignees tracked for recent-year momentum — including the field leader — shows zero filings in the latest year. Combined with the 2021 peak and the flat 2022 midpoint, this suggests the current filers have either paused, shifted strategy, or their newest filings have not yet published.
China leads receiving-office volume, US and EPO follow closely
China accounts for 17 filings, ahead of the EPO and US at 9 each, with Canada, Japan and Germany each in single digits. That distribution suggests China is the most active filing jurisdiction for this process chain, while EPO and US filings likely represent the higher-value or export-oriented inventions.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to starch processing and sweetener production, with the prior art for and against each one.
Who holds the ground, and where it opens up
The assignee ranking is concentrated but not closed — the gap between the top 5 and top 10 shows room for a second wave, and several sub-areas remain thinly claimed.
One assignee sets the pace
The top-ranked assignee holds 13 of the 49 records in scope, more than double the fifth-place count of 3. That gap is wide enough that any new entrant should expect to negotiate around the leader's claims specifically, not just the field average.
A tight cluster forms behind the leader
Fifth place holds 3 records and tenth place holds just 1, meaning the field flattens quickly outside the top few. Most of the 30 ranked assignees sit at this low end, filing once or twice rather than building a sustained portfolio.
Collaboration is limited and inventor-linked
Only 8 co-assignee pairs appear across the dataset, and the strongest links are between one corporate assignee and individual named inventors rather than between two companies. This points to filings built around specific inventor teams rather than formal joint-venture patenting.
| Assignee | Recent year | YoY |
|---|---|---|
| Danisco US Inc. | 0 | — |
| Zhejiang University of Technology | 0 | — |
| Zhejiang Huakang Pharmaceutical Co., Ltd. | 0 | — |
| Shandong University | 0 | — |
| Novo Nordisk A/S | 0 | — |
| Wuhan Jindege Sugar Co., Ltd. | 0 | — |
| Shandong Xiangchi Jianyuan Biotechnology Co., Ltd. | 0 | — |
| Huangmei Nanyang Biotechnology Co., Ltd. | 0 | — |
Where to take this analysis
The dataset points to specific next steps depending on whether the goal is freedom-to-operate, portfolio benchmarking, or drafting.
Run a freedom-to-operate check on the gate chips
The under-claimed sub-areas above — 5-HMF reduction, DE value control, co-product valorisation — show low IPC density but are not necessarily clear. Confirm against the full claim text before committing R&D spend.
Explore in EurekaTrack the leader's next filings
With every top-6 assignee showing zero filings in the latest tracked year, the next published batch will indicate whether the 2021 peak was a one-off push or the start of a new cycle.
Set up monitoring in EurekaBenchmark citation-heavy prior art before drafting
The most-cited records in this set date back to the 1990s and 2010s, meaning any new isomerization or ion-exchange claim needs to be checked against foundational patents, not just recent filings.
Review key patents in EurekaCommon questions on starch and sweetener patents
Within this 49-record dataset, filing is concentrated: the top 5 assignees together hold 61.2% of all records, and the top 10 hold 79.6%. The single leading assignee accounts for 13 records on its own, well ahead of the fifth-ranked assignee at 3. Beyond the top 10, the remaining 20 of the 30 ranked assignees each hold only a handful of filings, so the field has a clear leader group and a long tail rather than an even spread.
C12P, covering fermentation and enzymatic synthesis, appears on 75.5% of the 49 records and is the dominant class for this process chain. C12N (microorganisms and genetic engineering) follows at 42.9%, reflecting how much of the innovation here is enzyme-variant and organism-engineering work rather than pure mechanical processing. C13K, the class specifically for saccharides from natural sources, sits at 30.6% — lower than C12P, which tells you that enzyme and fermentation claims outnumber raw extraction-process claims in this space.
The trend in this dataset peaked in 2021 at 6 records and dropped to zero by the 2022 midpoint, with every one of the six top assignees tracked for recent-year momentum showing no filings in the latest year. That pattern reads as flat-to-declining rather than growing, though publication lag of roughly 18 months means the most recent one or two years will still fill in as pending applications publish. Anyone using this data for a go/no-go decision should treat the last two years as provisional rather than final.
This filing from Zhejiang Huakang Pharmaceutical describes a purification system for reducing 5-hydroxymethylfurfural content in high-fructose syrup, using a sequenced ion-exchange, heat-exchange and chromatographic-separation train to move an F42 stream to F55 grade. It is a system-and-method claim tied to a specific processing sequence, not a claim over isomerization or ion exchange generally, so it constrains a particular purification architecture rather than the whole refining step. Companies working on HMF control should review the exact sequencing and equipment claims rather than assume the whole downstream-refining space is blocked.
IPC classes with lower representation relative to the core C12P and C13K classes — such as A21D (baking applications) at 6.1% and A23K (animal feed) at 10.2% — suggest these application areas carry fewer direct process claims. Byproduct handling, including 5-HMF reduction and co-product gluten and fiber valorisation, also shows comparatively thin coverage against the density in core enzymatic and fermentation claims. These are starting points for a freedom-to-operate search, not confirmed clear space, since low IPC density does not rule out relevant claims filed under adjacent classifications.
Research Starch Processing and Sweetener Production in depth with Eureka
Go past this page: query the whole starch processing and sweetener production corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.